Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

IMV Inc IMVIQ

Healthcare Biotechnology
IMV Inc. is a Canada-based company. The Company has no business operations.


GREY:IMVIQ - Post by User

IMV Inc > US based firm takes 5.1% position in IMV
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(258)
•••
Comment by qwerty22on Jul 31, 2020 12:29am
228 Views
Post# 31347889

RE:US based firm takes 5.1% position in IMV

RE:US based firm takes 5.1% position in IMVhttps://www.reuters.com/article/brief-venrock-healthcare-capital-partner/brief-venrock-healthcare-capital-partners-ii-lp-reports-a-208-stake-in-altimmune-inc-as-of-june-15-idUSFWN2E20GD

Looks like those guys had acquired 20% of Altimmune by mid-June. One month before it exploded to $30.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities